You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萊茵生物(002166.SZ):與芬美意簽訂新合同 是基於對天然甜味劑及其他天然原料市場未來發展及成長性的判斷後作出的預測
格隆匯 06-29 15:05

格隆匯6月29日丨萊茵生物(002166.SZ)於2023年6月26日進行投資者關係活動暨線上交流會,就“公司現5年期的合同執行情況如何?能分享一下與帝斯曼-芬美意新簽訂的5年期合同重點內容和變化嗎?”,公司回覆稱,公司與芬美意2018年簽訂的5年期合同保底金額為3.45億美元,過去4年以來合同的執行情況基本與各年的保底目標未發生過重大偏差,符合雙方預期。2023年度剩餘應達成的採購金額約為1.37億美元,雙方也都在為順利達成今年銷售目標而努力。如最終未能順利完成採購目標,雙方將會按照合同相關約定執行。

公司與帝斯曼-芬美意簽訂的新合同執行週期是2024年至2028年,重要的變化一是合同金額的提升,保底交易金額約定為6.8億美元,目標金額約定為8.4億美元,新合同的簽訂是雙方基於對天然甜味劑及其他天然原料市場未來發展及成長性的判斷後作出的預測,金額較上期合同有了明顯的提升,也展現了公司與帝斯曼-芬美意一同對天然健康行業未來發展的充足信心。第二個重點變化是新合同中雙方對於客户開拓進行了更開放的約定。通過過去五年的合作,公司與帝斯曼-芬美意對於各自在天然甜味劑市場拓展的優勢都有了更清晰的認知,未來雙方對於客户的拓展將更注重成效性,來確定是由萊茵還是帝斯曼-芬美意更適合去執行開拓。上述條款的放寬對雙方及整個天然甜味劑業務的發展都將是積極的。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account